Welcome to Novatek Pharmaceuticals

Novatek Pharmaceuticals is a company with a renowned team leading clinical investigations focused on development of immunomodulatory drugs related to cancers and infectious diseases. Empowering naturally derived immunotherapy that is effective across various cancer types, with the goal of effectively boosting the immune system and T cell population in patients while reducing the adverse effects of disease or cytotoxic therapies.

We primarily work with Nigella Sativa (Black seeds) a natural derivative incorporated within our proprietary drug NP-101. Clinical trials conducted in 2021 demonstrated that NP-101 has applications for immunotherapy and cancer treatment showcasing significant effect on T cells. The Novatek team has 100+ years of clinical research and pharmaceutical development experience, resulting in 400+ peer reviewed publications and a strong pharmaceutical pipeline.

 Dr. Ahmed Kaseb founded Novatek Pharmaceuticals to conduct clinical research with a proprietary compound, NP-101, to address the need for immunomodulatory drugs . NP-101 is naturally derived from the seeds of the Nigella Sativa plant, commonly referred to as “black seeds”. 

LEARN MORE

Novatek Pharmaceuticals Inc., was recently formed based on years of experience with n-sativa in oncology patients combined with recent publications. Raising Series A to finance clinical trials in various cancers and to further develop the pipeline.

LEARN MORE

Novatek Pharmaceuticals main target is the concentrated form of the black seed oil. Black seed oil is a natural product with therapeutic potential in management of cancers and infectious diseases. NP-101 is the proprietary drug, naturally derived from this compound

LEARN MORE

We provide scientific guidance to the Consortium and advice on the strategic direction of our Project scientific guidance
LEARN MORE

N-Sativa, a component of NP-101, may block the SARS-CoV-2 entry via ACE2 in pneumocytes. N. sativa oil and n-sativa produce antinociceptive effects through indirect activation of supraspinal μ1- and κ-opioid receptor subtypes.
LEARN MORE

There is a pending story in collaboration with case CWRU School of Medicine to study the effect of NP-101 and cancer patients. Stay current with the latest news and events from Novatek Pharmaceuticals.
COMING SOON

Novatek Pharmaceuticals Initiates a Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study Of Its Oral Drug, NP-101, Against Novel Coronavirus 2019 (COVID-19) In The Outpatient Setting
LEARN MORE

In order to best meet our patients needs, Pyramids Pharmacy delivers Ground or Overnight, five days a week. You can be confident the medications will be delivered when needed.
LEARN MORE

Stay current with the latest news and events from Novatek Pharmaceuticals.
LEARN MORE

Novatek Pharmaceuticals Initiates a Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study Of Its Oral Drug, TQ Formula, Against Novel Coronavirus 2019 (COVID-19) In The Outpatient Setting
LEARN MORE

Thymoquinone may block the SARS-CoV-2 entry via ACE2 in pneumocytes. N. sativa oil and thymoquinone produce antinociceptive effects through indirect activation of supraspinal μ1- and κ-opioid receptor subtypes.
LEARN MORE

We provide scientific guidance to the Consortium and advice on the strategic direction of our Project scientific guidance
LEARN MORE

Novatek Pharmaceuticals main target is Black seed oil. Black seed oil is a natural product with therapeutic potential in management of SARS-CoV-2 due to its anti-viral activity.
LEARN MORE

Novatek Pharmaceuticals Inc., was recently formed based on years of experience with thymoquinone in oncology patients combined with recent publications.

LEARN MORE

Founders Mohamed, Osama and Karim, created Novatek Pharmaceuticals to develop and commercialize an innovative therapeutic approach to treat COVID-19. In other words, our product was driven by wanting to provide effective results to offer great health benefits with quality that lives up to the highest standards.
LEARN MORE

Novatek Pharmaceuticals Initiates a Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study Of Its Oral Drug, TQ Formula, Against Novel Coronavirus 2019 (COVID-19) In The Outpatient Setting
LEARN MORE

What we do

Novatek Pharmaceuticals main target is Black seed oil. Black seed oil is a natural product with therapeutic potential in management of SARS-CoV-2 due to its anti-viral activity.
LEARN MORE

Novatek Pharmaceuticals was founded by Dr. Ahmed Kaseb, MD.
Dr. Kaseb is a Professor at the University of Texas, MD Anderson Cancer Center.
LEARN MORE

Who we are

Novatek Pharmaceuticals Inc., was recently formed based on years of experience with thymoquinone in oncology patients combined with recent publications.

LEARN MORE

Connect with us

In order to best meet our patients needs, Pyramids Pharmacy delivers Ground or Overnight, five days a week. You can be confident the medications will be delivered when needed.
LEARN MORE

Stay current with the latest
news and events from Novatek Pharmaceuticals.
LEARN MORE

Thymoquinone may block the SARS-CoV-2 entry via ACE2 in pneumocytes. N. sativa oil and thymoquinone produce antinociceptive effects through indirect activation of supraspinal μ1- and κ-opioid receptor subtypes.
LEARN MORE

We provide scientific guidance to the Consortium and advice on the strategic direction of our Project scientific guidance
LEARN MORE

About Our Products

Black seed oil is a natural product with therapeutic potential in management of Cancer, SARS-CoV-2 and various diseases due to its anti-viral activity. Derived from Nigella Sativa plant, it has been extensively studied and shown to possess a wide spectrum of activities which include antibacterial, antifungal and antiviral effects among many others. These “black seeds” are utilized in NP-101 our naturally derived proprietary drug.

PRESS RELEASE:

Novatek Pharmaceuticals Initiates A Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study Of Its Oral Drug, NP-101, Against Novel Coronavirus 2019 (COVID-19) In The Outpatient Setting

Contact Us

Thank you for your interest in Novatek Pharmaceuticals. we look into all the messages send to us and we reply back to them in a timely manner

Please contact us